The 2017 Tel-Aviv Institutional Investment Conference
Israel’s Largest Institutional Investment Conference; Over $400 Billion Under Management
DC Finance is honored to present The 10th Tel Aviv Annual Institutional Conference, Israel’s largest event in the institutional space.
Over 400 CIOs, members of investment committees, investment and nostro managers from Israel’s leading insurance companies, pension, provident and endowment funds, family offices, banks and investment banks that
collectively manage over $400 Billion under management (not including capital managed by CFOs of large cap companies who attend as well), will join us on March 12th at the Hilton Tel Aviv
Panel: Investing in U.S. Senior Secured Corporate Loans
Investing and De-globilization- Mr. Jon Malmsäter, Director, KM Trading, Cayman Ltd.
Europe – The Investment Opportunity- Mr. Robert Bluhm, Product Manager, Bantleon & Mr. Roger Bergande, Senior Portfolio Manager, Systematic Markets, Bantleon
Financing – The Fifth Generation Tendency, Challenges and Opportunities in the Financing Arena-Ms. Orit Israeli, Adv., Amit, Pollak, Matalon & Co. APM Law Firm – for the presantation please contact the office
Extreme Risks -How to Avoid Them -Mr. Paul Skiba, Chief Risk Officer, BPM Berlin
In re VeriFone Holdings, Inc. Securities Litigation Impact on Israeli Investors-Mr. Christopher Wood, Director, litigation Dep., Robbins Geller LLP – No presentation
Enhanced cash tool\ETF for USD – Mr. Shay Yona, Head of Israel Coverage, Source UK
Emerging Hedge Fund Managers – Public and Private Market Opportunities – Ms. Abby Flamholz, Managing Member, Worth Venture Partners -for the presantation please contact the office
How to Turn a Trumpoline into a Springboard Using Real Estate Investments Oversees -Assaf Rosenheim, Investment manager, Profimex – for the presantation please contact the office
The speakers include CIOs, regulators, administration officials and academic lecturers from Israel and abroad.
Speakers include: Prof. Manuel Trajtenberg, Member of the Kenesset, former chairman of The Trajtenberg Commity | Prof. Shmuel Hauser, Chairman, Israel Securities Authority (ISA) | Dr. Gil Bafman, Chief Economist, Bank Leumi | Mr. Yossi Beinart, Chief Executive Officer, TASE | Mr. Robby Goldenberg, Senior Vice President, TASE | Mr. Alex Zabezhinsky, Chief Economist, Meitav Dash Investment House | Mr. Zvi Stepak, Chairman, DS-Meitav, Investment House | Prof. Zvi Weiner, Head of Finance Department, School of Business Administration, The Hebrew University of Jerusalem | Mr. Amir Hessel, Executive vice president, Chief Investments Officer, Harel Insurance & Finance | Mr. Yoni Tal, Chief Investment Officer, Menora Mivtachim Insurance | Mr. Gili Gershler, Head of Finance, School of Economics, The College of Management | Mr. Ori Greenfeld, Chief Economist & Strategist, Psagot | Mr. Nir Moroz, CIO, Psagot | Dr. Christopher Mellor, Head of Equity Product Management, Source | Mr. Gili Cohen, former Chief Investment Officer, Excellence Nessuah | Mr. Joel B. Strauss, Partner, Kaplan, Fox & Kilsheimer LLP | Mr. Ronen Matmon, Chief Investments Officer, Excellence Investment House | Mr. Elchanan Rosenheim, CEO, Profimex | Mr. Yaky Yanay, President and COO, Pluristem Therapeutics | Ms. Orit Israeli, Adv, partner, Amit Pollak Matalon | Mr. Meir Levin, Adv. – Senior Advisor to the Chairman and Director of the International Affairs Department, ISA | Ms. Heidi Lawson, Member, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., New York, NY USA | Mr. Adam L. Sisitsky, Member, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., Boston, MA USA | Mr. Chris Brennan, Partner, Addleshaw Goddard, London, UK| Mr. Ariel Berman, Zonal Manager Financial Institutions EMEA – AIG, London, UK| Mr. Tim Stevenson, Director, European Equities, Henderson | Mr. Matthew Michael, Product Director – Emerging Market Debt and Commodities, Schroders | Mr. Keith Kelsall CFA, Infrastructure Investment Director, Aviva Investors | Mr. David A. Rosenfeld, Partner, Robbins, Geller, Rudman & Dowd LLC | Mr. David Forbes-Nixon, Chairman and CEO, Alcentra Global Asset Management | Dr. Christopher Mellor, Head of Equity Product, Source |